|
The DASIS Report: Planned
Methadone Treatment for Non-Heroin Opiate Admissions Highlights
- Methadone is an opioid agonist
medication used to treat heroin and other opiate addiction. Methadone reduces
the craving for heroin and other opiates by blocking the receptor sites that are
affected by heroin or other opiates.
- Non-heroin
opiates include methadone, codeine, Dilaudid, morphine, Demerol, opium, oxycodone,
and any other drug with morphine-like effects.
- Based
on SAMHSA's 2000 Treatment Episode Data Set (TEDS), admissions with non-heroin
opiates as a primary substance of abuse accounted for 26,900 (10 percent) of the
269,400 opiate admissions. Methadone treatment was planned for 19 percent
of the non-heroin opiate treatment admissions.
- Non-heroin
opiate admissions with planned methadone treatment were almost twice as likely
as admissions with no planned methadone treatment to be self- or individually
referred (81 vs. 43 percent).
- Among
the non-heroin opiate admissions, methadone treatment was planned for 66 percent
of Asian/Pacific Islanders, 24 percent of Blacks, 20 percent of Hispanics, 17
percent of American Indian/Alaska Natives, and 17 percent of Whites.
Reports
on treatment Reports
on opiates Other
topics Other
OAS publications and services
This OAS Short Report,
The DASIS Report: Planned
Methadone Treatment for Non-Heroin Opiate Admissions, is based on the
Drug and Alcohol Services Information System (DASIS),
the primary source of national data on substance abuse treatment. DASIS
is conducted by the Office of Applied Studies (OAS) in the Substance Abuse and
Mental Health Services Administration (SAMHSA). For
PDF formats, click
here to download the Acrobat Adobe Reader and follow the instructions
for the free reader. |
